Tuberous sclerosis complex (TSC) is a genetic disorder characterized by frequent noncancerous neoplasia in the brain, which can induce a range of severe neuropsychiatric symptoms in humans, resulting from out of control tissue growth. The causative spontaneous loss-of-function mutations have been also identified in rats. Herein, we studied histopathological and molecular changes in brain lesions of the Eker rat model carrying germline mutation of the tsc2 gene, predisposed to multiple neoplasias. Predominant subcortical tumors were analyzed, along with a rare form occurring within the pyriform lobe. The uniform composition of lesions supports the histochemical parity of malformations, with immunofluorescence data supporting their neuro-glial origin. Massive depletion of mature neurons and axonal loss were evident within lesions, with occasional necrotic foci implying advanced stage of pathology. Enrichment of mesenchymal-derived cell markers with hallmarks of neurogenesis and active microglia imply enhanced cell proliferation, with local immune response. The depletion of capillaries within the core was complemented by the formation of dense mesh of nascent vessels at the interface of neoplasia with healthy tissue, implying large-scale vascular remodeling. Taken as a whole, these findings present several novel features of brain tumors in Eker rat model, rendering it suitable for studies of the pathobiology and progression of primary brain tumors, with therapeutic interventions.

Department of Experimental Neurobiology National Institute of Mental Health Topolová 748 250 67 Klecany Czech Republic

Department of Psychiatry and Medical Psychology 3rd Faculty of Medicine Charles University Ruská 87 100 00 Prague 10 Czech Republic

University Hospital Carl Gustav Carus Technical University Department of Child and Adolescent Psychiatry Dresden Fetscherstraße 74 01307 Dresden Germany

Zobrazit více v PubMed

Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125–7. doi: 10.1111/j.1749-6632.1991.tb37754.x. PubMed DOI

Yeung RS, Katsetos CD, Klein-Szanto A. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am J Pathol. 1997;151(5):1477–86. PubMed PMC

Fryer AE, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet. 1987;1(8534):659–61. doi: 10.1016/S0140-6736(87)90416-8. PubMed DOI

van Slegtenhorst M, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277(5327):805–8. doi: 10.1126/science.277.5327.805. PubMed DOI

Kandt RS, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet. 1992;2(1):37–41. doi: 10.1038/ng0992-37. PubMed DOI

Tee AR, et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci U S A. 2002;99(21):13571–6. doi: 10.1073/pnas.202476899. PubMed DOI PMC

Jones AC, et al. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis. Hum Mol Genet. 1997;6(12):2155–61. doi: 10.1093/hmg/6.12.2155. PubMed DOI

Kozlowski P, et al. Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Hum Genet. 2007;121(3–4):389–400. doi: 10.1007/s00439-006-0308-9. PubMed DOI

Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657–68. doi: 10.1016/S0140-6736(08)61279-9. PubMed DOI

Davis, P.E., et al., Presentation and Diagnosis of Tuberous Sclerosis Complex in Infants. Pediatrics, 2017. 140(6). PubMed PMC

Mizuguchi M, et al. Novel cerebral lesions in the Eker rat model of tuberous sclerosis: cortical tuber and anaplastic ganglioglioma. J Neuropathol Exp Neurol. 2000;59(3):188–96. doi: 10.1093/jnen/59.3.188. PubMed DOI

Gillberg IC, Gillberg C, Ahlsen G. Autistic behaviour and attention deficits in tuberous sclerosis: a population-based study. Dev Med Child Neurol. 1994;36(1):50–6. doi: 10.1111/j.1469-8749.1994.tb11765.x. PubMed DOI

de Vries PJ, et al. A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND) Am J Med Genet C Semin Med Genet. 2018;178(3):309–320. doi: 10.1002/ajmg.c.31637. PubMed DOI PMC

Bender BL, Yunis EJ. Central nervous system pathology of tuberous sclerosis in children. Ultrastruct Pathol. 1980;1(3):287–99. doi: 10.3109/01913128009141432. PubMed DOI

Nabbout R, et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry. 1999;66(3):370–5. doi: 10.1136/jnnp.66.3.370. PubMed DOI PMC

Eker R. Familial renal adenomas in Wistar rats; a preliminary report. Acta Pathol Microbiol Scand. 1954;34(6):554–62. doi: 10.1111/j.1699-0463.1954.tb00301.x. PubMed DOI

Waltereit R, et al. Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis. J Neurochem. 2006;96(2):407–13. doi: 10.1111/j.1471-4159.2005.03538.x. PubMed DOI

Rennebeck G, et al. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci U S A. 1998;95(26):15629–34. doi: 10.1073/pnas.95.26.15629. PubMed DOI PMC

Paxinos, G. and C. Watson, The Rat Brain In stereotaxic coordinates. 2007: Academic Press. 462.

Ovsepian SV, et al. Ambient Glutamate Promotes Paroxysmal Hyperactivity in Cortical Pyramidal Neurons at Amyloid Plaques via Presynaptic mGluR1 Receptors. Cereb Cortex. 2017;27(10):4733–4749. PubMed

O'Leary VB, et al. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons. Gene Ther. 2011;18(7):656–65. doi: 10.1038/gt.2011.8. PubMed DOI

Ovsepian SV, et al. Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Abeta) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. Brain Struct Funct. 2014;219(5):1527–41. doi: 10.1007/s00429-013-0583-x. PubMed DOI PMC

Bateup HS, et al. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron. 2013;78(3):510–22. doi: 10.1016/j.neuron.2013.03.017. PubMed DOI PMC

Nelson SB, Valakh V. Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders. Neuron. 2015;87(4):684–98. doi: 10.1016/j.neuron.2015.07.033. PubMed DOI PMC

Noroxe DS, Poulsen HS, Lassen U. Hallmarks of glioblastoma: a systematic review. ESMO Open. 2016;1(6):e000144. doi: 10.1136/esmoopen-2016-000144. PubMed DOI PMC

Bernal A, Arranz L. Nestin-expressing progenitor cells: function, identity and therapeutic implications. Cell Mol Life Sci. 2018;75(12):2177–2195. doi: 10.1007/s00018-018-2794-z. PubMed DOI PMC

Lin L, et al. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients. Tumour Biol. 2016;37(11):15333–15339. doi: 10.1007/s13277-016-5462-7. PubMed DOI

Ito D, et al. Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain. Stroke. 2001;32(5):1208–15. doi: 10.1161/01.STR.32.5.1208. PubMed DOI

Farnsworth RH, et al. Vascular remodeling in cancer. Oncogene. 2014;33(27):3496–505. doi: 10.1038/onc.2013.304. PubMed DOI

Takahashi DK, et al. Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex. Epilepsia. 2004;45(12):1525–30. doi: 10.1111/j.0013-9580.2004.23004.x. PubMed DOI

Wenzel HJ, et al. Morphology of cerebral lesions in the Eker rat model of tuberous sclerosis. Acta Neuropathol. 2004;108(2):97–108. doi: 10.1007/s00401-004-0865-8. PubMed DOI

Tschuluun N, Wenzel HJ, Schwartzkroin PA. Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability. Epilepsy Res. 2007;73(1):53–64. doi: 10.1016/j.eplepsyres.2006.08.003. PubMed DOI PMC

Lopes MB, et al. Immunohistochemical characterization of subependymal giant cell astrocytomas. Acta Neuropathol. 1996;91(4):368–75. doi: 10.1007/s004010050438. PubMed DOI

Hirose T, et al. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol. 1995;90(4):387–99. doi: 10.1007/BF00315012. PubMed DOI

Krinke GJ, et al. Morphologic characterization of spontaneous nervous system tumors in mice and rats. Toxicol Pathol. 2000;28(1):178–92. doi: 10.1177/019262330002800123. PubMed DOI

Nakamura R, et al. Availability of a microglia and macrophage marker, iba-1, for differential diagnosis of spontaneous malignant reticuloses from astrocytomas in rats. J Toxicol Pathol. 2013;26(1):55–60. doi: 10.1293/tox.26.55. PubMed DOI PMC

Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell. 1990;60(4):585–95. doi: 10.1016/0092-8674(90)90662-X. PubMed DOI

Tohyama T, et al. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest. 1992;66(3):303–13. PubMed

Kitai R, et al. Nestin expression in astrocytic tumors delineates tumor infiltration. Brain Tumor Pathol. 2010;27(1):17–21. doi: 10.1007/s10014-009-0261-0. PubMed DOI

Mokry J, et al. Nestin expression by newly formed human blood vessels. Stem Cells Dev. 2004;13(6):658–64. doi: 10.1089/scd.2004.13.658. PubMed DOI

Suzuki S, et al. The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem. 2010;58(8):721–30. doi: 10.1369/jhc.2010.955609. PubMed DOI PMC

Sugawara K, et al. Nestin as a marker for proliferative endothelium in gliomas. Lab Invest. 2002;82(3):345–51. doi: 10.1038/labinvest.3780428. PubMed DOI

Mendez-Ferrer S, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010;466(7308):829–34. doi: 10.1038/nature09262. PubMed DOI PMC

Sorrells SF, et al. Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults. Nature. 2018;555(7696):377–381. doi: 10.1038/nature25975. PubMed DOI PMC

Arai H, et al. Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas. Brain Tumor Pathol. 2012;29(3):160–7. doi: 10.1007/s10014-012-0081-5. PubMed DOI

Mizuguchi M, et al. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia. Acta Neuropathol. 2002;104(4):418–24. doi: 10.1007/s00401-002-0575-z. PubMed DOI

Boer K, et al. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers. Epilepsia. 2009;50(12):2629–37. doi: 10.1111/j.1528-1167.2009.02191.x. PubMed DOI

Kolenda-Roberts HM, et al. Immunohistochemical characterization of spontaneous and acrylonitrile-induced brain tumors in the rat. Toxicol Pathol. 2013;41(1):98–108. doi: 10.1177/0192623312452492. PubMed DOI

Tremblay R, Lee S, Rudy B. GABAergic Interneurons in the Neocortex: From Cellular Properties to Circuits. Neuron. 2016;91(2):260–92. doi: 10.1016/j.neuron.2016.06.033. PubMed DOI PMC

De Palma M, Biziato D, Petrova TV. Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer. 2017;17(8):457–474. doi: 10.1038/nrc.2017.51. PubMed DOI

Biomolecules to Biomarkers? U87MG Marker Evaluation on the Path towards Glioblastoma Multiforme Pathogenesis

All-Trans Retinoic Acid Fosters the Multifarious U87MG Cell Line as a Model of Glioblastoma

mTOR inhibitor improves autistic-like behaviors related to Tsc2 haploinsufficiency but not following developmental status epilepticus

Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes